A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme.

Conclusions: The risk signature may contribute to GBM diagnosis in future clinical practice. PMID: 31531345 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31531345?dopt=Abstract

Source: Biomed Res - September 19, 2019 Category: Research Authors: Zhao J, Wang L, Hu G, Wei B Tags: Biomed Res Int Source Type: research